New 52 Week High Today

Third Harmonic Bio Inc THRD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/20/24 EDT
14.40UNCH (UNCH)
Volume
3,970
Close
14.40UNCH (UNCH)
Volume
91,839
52 week range
4.51 - 15.00
Loading...
  • Open13.87
  • Day High15.00
  • Day Low13.71
  • Prev Close13.87
  • 52 Week High15.00
  • 52 Week High Date05/20/24
  • 52 Week Low4.51
  • 52 Week Low Date06/02/23

Key Stats

  • Market Cap586.287M
  • Shares Out40.71M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change31.27

KEY STATS

  • Open13.87
  • Day High15.00
  • Day Low13.71
  • Prev Close13.87
  • 52 Week High15.00
  • 52 Week High Date05/20/24
  • 52 Week Low4.51
  • 52 Week Low Date06/02/23
  • Market Cap586.287M
  • Shares Out40.71M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change31.27

RATIOS/PROFITABILITY

  • EPS (TTM)-0.75
  • P/E (TTM)-19.26
  • Fwd P/E (NTM)-11.00
  • EBITDA (TTM)-43.919M
  • ROE (TTM)-11.05%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Third Harmonic Bio Inc

 

Profile

MORE
Third Harmonic Bio, Inc. is a biopharmaceutical company. The Company is focused on advancing the next wave of medicine for inflammatory diseases through the development of novel, small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is developing medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. Mast cells are a part of the immune...
Mark Iwicki
Independent Chairman of the Board
Natalie Holles
Chief Executive Officer, Director
Christopher Murphy
Chief Financial and Business Officer and Principal financial officer
Address
1700 Montgomery Street, Suite 210
San Francisco, CA
94111
United States

Top Peers

SYMBOLLASTCHG%CHG
KRRO
Korro Bio Inc
54.60UNCHUNCH
APLT
Applied Therapeutics Inc
4.20UNCHUNCH
SLRN
ACELYRIN Inc
4.30UNCHUNCH
STTK
Shattuck Labs Inc
7.45UNCHUNCH
CRBP
Corbus Pharmaceuticals Holdings Inc
48.55UNCHUNCH